Omar Abdel-Wahab, M.D.
Memorial Sloan-Kettering Cancer Center The Role of ASXL1
mutations in leukemia patients...more
Memorial Sloan-Kettering Cancer Center The Role of ASXL1
mutations in leukemia patients...more
All Grantees
Memorial Sloan-Kettering Cancer Center The Role of ASXL1
mutations in leukemia patients...more
Scott A. Armstrong, M.D., Ph.D.
Children's Hospital, Dana Farber Cancer Institute Epigenetic
Programs in MLL-rearranged leukemias...more
Jennifer Amengual, M.D.
NYU Cancer Institute, New York University School of Medicine
Therapeutic Targeting of the BCL6; p53 axis with Histone
Deactylase Inhibitors...more
Iannis Aifantis, Ph.D., B.S.
NYU Cancer Institute, New York University School of Medicine
Modeling T-Cell A.L.L....more
Juliet N. Barker, MBBS (Hons), FRACP
Memorial Sloan-Kettering Cancer Center Double Unit Grafts
for the Treatment of High Risk Hematologic Malignancies...more
Gregory L. Beatty, M.D., Ph.D.
University of Pennsylvania Medical Center Targeting
inflammation within the tumor microenvironment for cancer
therapy...more
Iris Bell, M.D., Ph.D.
Andreas Beutler, M.D.
Mount Sinai School of Medicine An Integrative Approach to
the Control of Intractable Pain from Cancer such as Multiple
Myeloma...more
